We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Johnson & Johnson is challenging findings from several research studies published in the British Medical Journal (BMJ) which question the safety of all-metal hip implants. Johnson & Johnson, along with its subsidiary DePuy Orthopedics, is currently facing thousands of lawsuits in the U.S. and around the world in connection with
Boehringer Ingelheim, maker of the increasingly popular anticoagulant drug Pradaxa, has announced that it will establish a new patient registry which will allow the company to track the safety of Pradaxa for patients suffering from a heart rhythm condition known as atrial fibrillation (AF). The GLORIA(TM)-AF Registry is expected to
Since Johnson & Johnson’s DePuy Orthopedics division announced a recall of its ASR all-metal hips in 2010, the company has faced an increasing number of lawsuits filed on behalf of patients who claim they were injured by one of these devices. As new lawsuits continue to mount, a Nevada judge
The blood-thinning drug Pradaxa (dabigatran) has been linked to a number of serious complications, including an increased risk of serious and in some cases, fatal, bleeding events. Boehringer Ingelheim, the company that manufactures Pradaxa, acknowledged in November 2011 that the drug was responsible for approximatley 260 deaths worldwide. A new
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has issued a new warning advising doctors against using a specific combination of metal hip implant components. The MHRA issued the warning after it was determined that the patients who received the metal hips in question had an “unacceptably high” rate
A third multidistrict litigation (MDL) has been established to handle federal lawsuits involving defective metal hip implants. The newest MDL involves lawsuits filed in connection with the Conserve metal hip, manufactured by Wright Medical Technologies. According to court documents, the U.S. Judicial Panel on Multidistrict Litigation voted to consolidate federal
The U.K.’s top medical-cost regulator is putting its support behind Pradaxa for the prevention of blood clots in patients who suffer from a heart rhythm condition known as atrial fibrillation (AF). The announcement comes as concerns continue to mount over the safety of Pradaxa, which has been linked to numerous
Amid a growing firestorm of controversy surrounding defective metal hip implants, the British Hip Society is now urging physicians in the UK to stop using the all-metal devices in patients requirement hip replacement surgery. The warning comes just days after the Medicines and Healthcare products Regulatory Agency (MHRA) issued new
The British Medical Journal (BMJ) recently announced that an investigation into failing metal hip implants has revealed that thousands of patients may potentially suffer toxic poisoning caused by these devices. According to an article published in The Daily Mail, the British Medical Journal partnered with the BBC to investigate reports
Johnson & Johnson’s DePuy Orthopedics is once again the subject of scrutiny as new reports surface that the company marketed a metal hip implant to patients overseas, despite the fact that the FDA failed to grant approval for the device in the U.S. According to a February 14th article published
“The post I wrote for your site was far more successful than any other post I’ve ever done!” Ian Nuttall
“Fantastic Service. Went above and beyond to highlight the good work done by our law firm.” Cian
